American Oncology Network Inc.Eigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 12 USD | 13,95 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 29.248.362 | 0,39 | 0,63 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name American Oncology Network Inc.
Mitarbeiter 1.914
Handelsplatz NASDAQ
Ticker Symbol AONC
IPO Datum 2021-05-05
Adresse 14543 Global Parkway, Fort Myers, FL, United States, 33913
Webseite https://www.aoncology.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Todd Schonherz | CEO & Director |
| 2 | Dr. Stephen Divers M.D. | Chief Medical Officer, Vice Chairman & Chairman of Advisory Board Executive Committee |
| 3 | Mr. David Afshar CPA | Principal Accounting Officer, CFO & COO |
| 4 | Mr. Mark Moch | Chief Information Officer |
| 5 | Ms. Kristin Matisziw | Chief Compliance & Risk Officer |
| 6 | Mr. Charlie Goddard II | General Counsel |
| 7 | Ms. Caroline Hewitt | Vice President of Marketing |
| 8 | Ms. Terri Casey | Chief Human Resources Officer |
| 9 | Mr. James Gilmore Pharm.D. | Chief Pharmacy & Clinical Services Officer |
| 10 | Ms. Karen Pilley | Chief Revenue Cycle Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.